Williams Hart & Boundas, LLP has joined a team of leading plaintiffs' law firms to achieve a $7.25 billion settlement class action against Monsanto that would resolve thousands of existing and future claims involving Roundup exposure and non-Hodgkin lymphoma (NHL). The settlement, filed on February 17, 2026, by Williams Hart & Boundas, Waters Kraus Paul & Siegel, Motley Rice, Seeger Weiss, and the Holland Law Firm, in the City of St. Louis Circuit Court will establish a structured compensation framework for individuals diagnosed with NHL following exposure to Monsanto's glyphosate-based herbicide.
Over the past several years, juries nationwide have returned significant verdicts linking Roundup to non-Hodgkin lymphoma, while tens of thousands of claims remain pending in state and federal courts. 'After years of pressing cases against Monsanto and in light of the fact that the U.S. Supreme Court has accepted an appeal to review the validity of these Round-Up claims, we are pleased to achieve a resolution that we believe is acceptable based on the current circumstances,' said John Eddie Williams, Jr., Founding and Managing Partner of Williams Hart & Boundas, LLP.
According to the settlement, Monsanto will fund up to $7.25 billion to compensate a class that includes virtually all existing and certain future Roundup cancer claims. The agreement is designed to provide a structured and comprehensive resolution framework for individuals diagnosed with non-Hodgkin lymphoma following exposure to the herbicide. Under the proposed settlement, eligible class members will have the right to opt out and pursue their claims individually if they choose. For more information about the settlement, please contact Williams Hart & Boundas, LLP at 713-940-6220. The case is filed in St. Louis city court.
This settlement represents a significant development in the ongoing litigation against Monsanto, as it provides a mechanism to resolve a large volume of claims while avoiding prolonged court battles. The structured compensation framework is intended to ensure that claimants receive timely payments based on the severity of their illness and exposure history. The agreement also addresses future claims, offering a path to compensation for individuals who may develop NHL after exposure to Roundup. The involvement of multiple law firms underscores the complexity of the case and the coordinated effort required to achieve a resolution. The settlement is subject to court approval, and class members will have the opportunity to opt out if they prefer to pursue individual lawsuits. The outcome could set a precedent for how mass tort cases involving widespread exposure to potentially harmful products are resolved in the future.
